Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
82.5
USD
0.05%
Market Closed
Market Cap:
$47.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Edwards Lifesciences Corp
NYSE:EW
|
US |
|
Blend Labs Inc
NYSE:BLND
|
US |
|
Grupo Aeroportuario del Pacifico SAB de CV
NYSE:PAC
|
MX |
|
AAR Corp
NYSE:AIR
|
US |
|
Amryt Pharma Holdings Ltd
LSE:AMYT
|
UK |
|
E
|
East Coast Furnitech PCL
SET:ECF
|
TH |
|
Banco de Chile
NYSE:BCH
|
CL |
|
Culti Milano SpA
MIL:CULT
|
IT |
|
Cikarang Listrindo Tbk PT
IDX:POWR
|
ID |
|
Microport Scientific Corp
HKEX:853
|
CN |
|
H
|
Henan Zhongyuan Expressway Co Ltd
SSE:600020
|
CN |
|
B
|
Boutique Newcity PCL
SET:BTNC
|
TH |
Relative Value
The Relative Value of one
EW
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 82.5 USD,
Edwards Lifesciences Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EW Relative Value
HIDDEN
Multiples Across Competitors
EW Competitors Multiples
Edwards Lifesciences Corp Competitors
Edwards Lifesciences Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.1B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 5.1 | 39.6 | 20.2 | 24.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.9B USD | 2 | 25 | 9.9 | 16.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.7B USD | 1.5 | 15.2 | 11 | 13.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
